V Square Quantitative Management LLC Acquires 180 Shares of Maximus, Inc. (NYSE:MMS)

V Square Quantitative Management LLC boosted its position in Maximus, Inc. (NYSE:MMS) by 65.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 453 shares of the health services provider’s stock after buying an additional 180 shares during the quarter. V Square Quantitative Management LLC’s holdings in Maximus were worth $34,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Sanctuary Advisors LLC bought a new position in Maximus during the 2nd quarter valued at about $216,000. Creative Planning grew its holdings in Maximus by 7.8% during the third quarter. Creative Planning now owns 16,386 shares of the health services provider’s stock valued at $1,527,000 after purchasing an additional 1,181 shares during the period. Net Worth Advisory Group acquired a new position in Maximus during the third quarter valued at approximately $259,000. Blue Trust Inc. boosted its holdings in shares of Maximus by 234.2% in the third quarter. Blue Trust Inc. now owns 1,310 shares of the health services provider’s stock valued at $112,000 after buying an additional 918 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Maximus by 1.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 705,400 shares of the health services provider’s stock worth $65,715,000 after purchasing an additional 8,667 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on MMS shares. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday.

Maximus Price Performance

MMS stock opened at $67.69 on Tuesday. The company has a quick ratio of 1.49, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 12 month low of $66.52 and a 12 month high of $93.97. The firm has a market cap of $3.87 billion, a P/E ratio of 14.56 and a beta of 0.72. The company’s 50-day moving average price is $74.05 and its two-hundred day moving average price is $82.24.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, analysts anticipate that Maximus, Inc. will post 6.05 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.77%. Maximus’s dividend payout ratio is presently 25.81%.

Insider Buying and Selling

In other news, CEO Bruce Caswell purchased 3,500 shares of the company’s stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the transaction, the chief executive officer now owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Raymond B. Ruddy purchased 3,490 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the transaction, the director now directly owns 112,520 shares in the company, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 7,063 shares of company stock worth $502,017 in the last ninety days. Company insiders own 1.60% of the company’s stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.